Choi, E.M.-L.; Kasonia, K.; Kavunga-Membo, H.; Mukadi-Bamuleka, D.; Soumah, A.; Mossoko, Z.; Edwards, T.; Tetsa-Tata, D.; Makarimi, R.; Toure, O.;
et al. Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo. Vaccines 2024, 12, 828.
https://doi.org/10.3390/vaccines12080828
AMA Style
Choi EM-L, Kasonia K, Kavunga-Membo H, Mukadi-Bamuleka D, Soumah A, Mossoko Z, Edwards T, Tetsa-Tata D, Makarimi R, Toure O,
et al. Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo. Vaccines. 2024; 12(8):828.
https://doi.org/10.3390/vaccines12080828
Chicago/Turabian Style
Choi, Edward Man-Lik, Kambale Kasonia, Hugo Kavunga-Membo, Daniel Mukadi-Bamuleka, Aboubacar Soumah, Zephyrin Mossoko, Tansy Edwards, Darius Tetsa-Tata, Rockyath Makarimi, Oumar Toure,
and et al. 2024. "Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo" Vaccines 12, no. 8: 828.
https://doi.org/10.3390/vaccines12080828
APA Style
Choi, E. M.-L., Kasonia, K., Kavunga-Membo, H., Mukadi-Bamuleka, D., Soumah, A., Mossoko, Z., Edwards, T., Tetsa-Tata, D., Makarimi, R., Toure, O., Mambula, G., Brindle, H., Camacho, A., Connor, N. E., Mukadi, P., McLean, C., Keshinro, B., Gaddah, A., Robinson, C.,
... Muyembe-Tamfum, J. J., on behalf of the Tujiokowe Study Consortium.
(2024). Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo. Vaccines, 12(8), 828.
https://doi.org/10.3390/vaccines12080828
